Trials / Completed
CompletedNCT02248155
Observational Study of Sifrol® in Patients With Primary Restless Legs Syndrome (RLS)
Sifrol® Onset of Action and Impact on RLS: A 12-week Observational Study in Patients With Primary RLS
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,644 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The objectives of this Post Marketing Surveillance (PMS) are: * Evaluation of the treatment effect of pramipexole on Restless Legs Syndrome (RLS) severity as measured by International Restless Legs Syndrome Scale (IRLS) and Clinical Global Impression Improvement scale (CGI- I) * Evaluation of the time to reaching maintenance dose of pramipexole * Evaluation of work productivity impairment associated with RLS based on the Work Productivity and Activity Impairment Questionnaire (WPAI) questionnaire
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pramipexole |
Timeline
- Start date
- 2006-04-01
- Primary completion
- 2006-11-01
- First posted
- 2014-09-25
- Last updated
- 2014-09-25
Source: ClinicalTrials.gov record NCT02248155. Inclusion in this directory is not an endorsement.